Skip to content

13F-HR filed by NOVO HOLDINGS A/S

NOVO HOLDINGS A/S filed this 13F-HR for the quarter ended 2022-03-31, filed 2022-05-16, with 53 holding rows worth $2,354,941,000.

Accession
0000950123-22-005953
Filed
2022-05-16
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2022

A holdings report, 53 entries on the cover page, a total value of $2,354,941,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,354,939,000 with VALUE read as thousands by filing date, 13F file number 028-16231. A later restatement replaced it, so the quarter does not use it. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
VTI922908769COM1,525,550$347,322,000thousands by filing date
EVOTEC SE FSPONSORED ADR 1 ADR REPS 0.5 ORD SHS30050E105Equity17,894,807$270,748,000thousands by filing date
EXSCIENTIA PLC30223G102ADS13,086,600$188,447,000thousands by filing date
BROOKFIELD ASSET MANAGEMENT IN112585104CL A LTD VT SH2,921,171$165,251,000thousands by filing date
Boston Scientific Corporation101137107COM3,463,577$153,402,000thousands by filing date
ASMLHLDGNVFSPONSOREDADR1ADRREPS1ORDSHSN07059210STOK215,099$143,671,000thousands by filing date
CATALENT INC USD 0.01148806102COM1,271,707$141,032,000thousands by filing date
Apple Inc037833100COM610,879$106,666,000thousands by filing date
MORPHIC HLDG INC61775R105COM1,634,811$65,638,000thousands by filing date
Salesforce.com, Inc79466L302COM299,000$63,484,000thousands by filing date
ARCELLX INC COMMON STOCK03940C100Stock4,016,878$56,317,000thousands by filing date
ALIBABA GROUP HLDG LTD01609W102SPONSORED ADS500,827$54,490,000thousands by filing date
EDGEWISE THERAPEUTICS INC28036F105COM5,587,207$54,196,000thousands by filing date
MIRUM PHARMACEUTICALS INC604749101COM2,200,000$48,444,000thousands by filing date
TAIWAN SEMICONDUCTOR MFG874039100SPONSORED ADS458,780$47,832,000thousands by filing date
INOGEN INC45780L104COM1,072,735$34,778,000thousands by filing date
NKARTA INC65487U108COMMON STOCK2,793,863$31,794,000thousands by filing date
AMICUS THERAPEUTICS INC03152W109COM2,560,211$24,245,000thousands by filing date
CABLE ONE INC12685J105COM15,873$23,242,000thousands by filing date
CYTEIR THERAPEUTICS INC23284P103COMMON4,840,413$18,248,000thousands by filing date
IO BIOTECH INC449778109COM3,277,932$17,373,000thousands by filing date
VERVE THERAPEUTICS INC92539P101COM750,000$17,115,000thousands by filing date
INSMED INC COM PAR $.01457669307Stock705,838$16,587,000thousands by filing date
Milestone Pharmaceuticals Inc59935V107COM2,530,003$16,243,000thousands by filing date
VECTIVBIO HLDG AGH9060V101COM3,380,402$15,922,000thousands by filing date
LAVA THERAPEUTICS NVN51517105SHS3,327,312$14,640,000thousands by filing date
BLUEPRINT MEDICINES CORP09627Y109COM227,526$14,534,000thousands by filing date
IOVANCE BIOTHERAPEUTICS INC462260100COM836,518$13,928,000thousands by filing date
BOLT BIOTHERAPEUTICS INC097702104COM4,503,991$12,341,000thousands by filing date
SILK ROAD MEDICAL INC82710M100COMMON STOCK276,068$11,399,000thousands by filing date
INARI MED INC45332Y109COM123,122$11,160,000thousands by filing date
INSPIRE MED SYS INC COM457730109Stock41,448$10,639,000thousands by filing date
SEASPINE HLDGS CORP81255T108COM858,752$10,442,000thousands by filing date
PULMONX CORP745848101COM410,155$10,176,000thousands by filing date
RENEO PHARMACEUTICALS INC75974E103COM3,430,377$10,085,000thousands by filing date
ROCKET PHARMACEUTICALS INC77313F106COM612,822$9,719,000thousands by filing date
TREACE MED CONCEPTS INC89455T109COM500,421$9,463,000thousands by filing date
PHARVARIS NVN69605108COMMON STOCK516,321$9,366,000thousands by filing date
CRINETICS PHARMACEUTICALS INC COM22663K107Stock424,897$9,326,000thousands by filing date
MINERVA SURGICAL INC60343F106COM2,048,892$9,220,000thousands by filing date
SPRUCE BIOSCIENCES INC85209E109COM4,514,336$9,074,000thousands by filing date
KINNATE BIOPHARMA INC49705R105COM624,236$7,029,000thousands by filing date
CHECKMATE PHARMACEUTICALS IN162818108COM2,161,990$6,897,000thousands by filing date
GALERA THERAPEUTICS EQUICLASS EQUITY36338D108COMMON STOCK2,459,021$5,852,000thousands by filing date
GALECTO INC36322Q107COM2,497,791$5,495,000thousands by filing date
AKOUOS INC00973J101COM1,061,990$5,044,000thousands by filing date
MARQETA INC57142B104CLASS A COM441,558$4,875,000thousands by filing date
ALIGOS THERAPEUTICS INC COM NEW01626L105Stock1,950,000$4,193,000thousands by filing date
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock25,000$4,082,000thousands by filing date
SPERO THERAPEUTICS INC84833T103COM468,902$4,079,000thousands by filing date
VERONA PHARMA PLC925050106SPONSORED ADS761,205$3,798,000thousands by filing date
RALLYBIO CORP75120L100COM435,944$3,043,000thousands by filing date
PRAXIS PRECISION MEDICINES I74006W108COM250,000$2,553,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000950123-22-005953this filing2022-05-16acceptance time not in the bulk data set
13F-HR/A 0000950123-22-006736 base2022-05-27acceptance time not in the bulk data set